BACKGROUND
Anakinra is effective in recurrent pericarditis, yet optimal treatment duration and strategies for safe drug discontinuation remain uncertain. Identifying predictors of sustained remission after discontinuation is important for clinical management.
METHODS
We retrospectively analyzed 185 consecutive adult...
Danilo Malandrino, Alessandra Bettiol, A. Andreis et al.· Journal of the American Hear...· 0 citations
INTRODUCTION
Although often self-limited, acute pericarditis recurs in up to 30% of patients. Recurrent pericarditis (RP) causes substantial morbidity (pain, fatigue, and impaired quality of life) and can lead to constriction. Traditional treatments have important limitations, including corticosteroid dependence, recur...
M. Imazio, Valentino Collini, Francesco Venturelli et al.· Expert Opinion on Emerging D...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.